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INTRODUCTION:  Patients  with  thymoma  are  found  to have  another  systemic  illness  and  a  broadly
increased  risk  for secondary  malignancies.  We  present  the  case  of  a 53-year-old  female  patient  who
harbored  two  synchronous  primary  malignant  neoplasms—an  anaplastic  oligodendroglioma  of the right
frontal  lobe  and  an anterior  mediastinal  thymoma.
PRESENTATION  OF  CASE:  A 53-year-old  female  patient  presented  in  her  ﬁrst hospital  admission  with
nausea,  chest  pain  and  non-pulsatile  bitemporal  headache.  Continued  headache  and  nausea  along  with
negative  cardiac  ﬁndings  prompted  radiological  evaluation  including  chest  CT  scan  and  brain  CT  scan
which  revealed  simultaneous  anterior  mediastinal  mass  and  frontal  lobe  calciﬁcation  respectively.  The
patient underwent  craniotomy  and  the  pathological  diagnosis  was  anaplastic  oligodendriglioma.  The
anterior  mediastinal  tumor  resection  was  performed  three  months  later,  while  the  patient  had  no newly
onset  of  any  symptoms  necessitating  more  investigation.
DISCUSSION:  Multiple  primary  malignancies  have  been  diagnosed  by  the  following  criteria:  each  tumor
must  have  an obvious  picture  of  malignancy,  each  must  be separate  and  discrete  and  the probability  that
one  was  a metastatic  lesion  from  the  other  must  be  excluded.  Treatment  strategies  in cases  of  double
malignancy  involve  treating  the  malignancy  that  is  more  advanced  ﬁrst.  In our case  we  concluded  that
synchronous  double  malignancy  can  be treated  successfully  according  to  the above  mentioned  criteria.
CONCLUSION:  Clinicians  should  be aware  of the  possibility  of  synchronous  malignancies  in  order  to
use  screening  procedures  in  patients  with  reported  increased  risk  of double  malignancy.  Such  clinical
alertness  may  lead  to a better  outcome  for double  primary  tumor  cases.
©  2016  The  Authors.  Published  by Elsevier  Ltd.  on  behalf  of  IJS Publishing  Group  Ltd.  This is  an  open
he  CCaccess  article  under  t
. Introduction
Patients with thymoma are found to have another systemic
llness and a broadly increased risk for cancer. The secondary malig-
ancies that have been described in these patients include both
ommon cancers (e.g., cancers of the lung, thyroid, and prostate,
nd lymphomas) and rare malignancies (e.g., brain tumors, sar-
omas, and leukemias). We  present a patient who harbored
wo uncommon synchronous primary malignant neoplasms—an
naplastic oligodendroglioma and an anterior mediastinal thy-
oma.  The purpose of this article is to increase the awareness of the
linicians to this possibility in order to use screening procedures in
atients with reported increased risk of double malignancy.∗ Corresponding author at: Rasoul Akram Hospital, Niayesh Ave., Sattar khan St.,
ehran, Iran. Fax: +98 21 66509056.
E-mail addresses: dr m vaziri@yahoo.com, vaziri.m@iums.ac.ir (M.  Vaziri).
ttp://dx.doi.org/10.1016/j.ijscr.2016.02.029
210-2612/© 2016 The Authors. Published by Elsevier Ltd. on behalf of IJS Publishing Gro
http://creativecommons.org/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
2. Presentation of case
A 53-year-old female patient presented in her ﬁrst hospital
admission with nausea, chest pain and non-pulsatile bitempo-
ral headache. The patient while consuming aspirin, atenolol and
atorvastatin was a non-smoker without any other underlying dis-
ease or addiction except hypertension and had normal physical
examination and laboratory tests. The primary presumed diagnosis
was acute coronary syndrome leading to cardiac evaluation which
proved to be normal. There was no family history of any disease and
the patient had an acceptable lifestyle with no anxiety or depres-
sion or any other psychiatric disorder. Continued headache and
nausea along with controlled hypertension and negative ﬁndings
in other organ systems prompted neurologist consultation with a
suspected intracranial lesion.
The radiological evaluation including chest CT scan and brain CT
scan revealed simultaneous anterior mediastinal mass and frontal
lobe calciﬁcation respectively (Fig. 1). Abdominal–pelvic CT scan
was also performed which was  normal. Further assessment includ-
ing brain MRI  and more complete neurologic exam showed a
frontal lobe mass (Fig. 2) and normal muscles force, reﬂexes, cranial
nerves function and no gait disturbance. CT-guided biopsy of the
up Ltd. This is an open access article under the CC BY-NC-ND license
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Fig. 1. Chest CT scan and brain CT scan show a well-deﬁned anterior mediastinal
mass with no adjacent tissues invasion and frontal lobe calciﬁcation respectively.
Fig. 2. Brain MRI  shows a frontal lobe mass.
Fig. 3. Pathological diagnosis of anaplastic oligodendriglioma WHO  grade III.
Fig. 4. Mixed lymphoepithelial thymoma WHO  type B2, composed of admixures of
thymic epithelial cells and small lymphocytes.mediastinal mass was reported highly suggestive for thymoma and
further evaluation revealed no evidence of myasthenia gravis or
gastro-intestinal disorder and also a normal thyroid function test.
Plasma and urinary cathecolamines and their metabolites were also
negative.
The patient underwent craniotomy with no post-operative
complication and the pathological diagnosis was anaplastic oligo-
dendriglioma WHO  grade III with multiple areas of calciﬁcation.
By immunohistochemistry, the tumoral cells were positive for glial
ﬁbrillary acidic protein (GFAP) and negative for CD 45, CD 20 and
CD 3. MIB-I index were about 20% (Fig. 3). The anterior medi-
astinal tumor resection via median sternotomy was performed
three months later, while the patient had no newly onset of
any symptoms necessitating more investigation. The completely
resected tumor had no surrounding structures invasion or metas-
tases. Pathological diagnosis was a grossly and microscopically
encapsulated 10 × 11 × 6 cm thymoma (type B2) (Fig. 4). The adju-
vant treatment for anaplastic oligodendroglioma included about
30 sessions of radiotherapy plus chemotherapy according to the
oncologist discretion. The patient has undergone a regular follow-
up for one year with no recurrence or any other complication or
new lesion in her latest brain and chest CT Scan. (Fig. 5).
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Wig. 5. Post-operative brain and chest CT Scan (one year later) which shows no
ecurrence or new lesion.
. Discussion
Patients with thymoma are found to have another systemic
llness including myasthenia gravis, pure red cell aplasia, hypo-
ammaglobulinemia, polymyositis, systemic lupus erythematosus,
hyroiditis, Sjogren’s syndrome, ulcerative colitis, pernicious ane-
ia, Addison’s disease, scleroderma, and panhypopituitarism. In
ddition, patients with thymoma are more likely to experience
xtrathymic neoplasms and the incidence of extrathymic cancer
s increased both before and after the diagnosis of thymoma.
Moertel [1] in his study of 37,580 cases of malignant disease,
eported multiple primary malignant tumors in 10.6% of autopsy
ases and 4.6% of surgical cases. Multiple primary malignancies
ave been diagnosed by the following criteria: each tumor must
ave an obvious picture of malignancy, each must be separate and
iscrete and the probability that one was a metastatic lesion from
he other must be excluded.
Engels and Pfeiffer [2] in a 2003 study, used SEER data to
ssess cancer incidence in 733 U.S. thymoma patients relative to
he general population. Secondary malignancies occurred in 66
9%) thymoma patients. Speciﬁc malignancies for which thymoma
atients had an increased risk included cancers of the digestive sys-
em as a group, non-Hodgkin lymphoma and soft tissue sarcomas.Masaoka et al. [3] reported a series of 392 patients who required
hymectomy for myasthenia gravis; 102 patients had thymomas of
hich nine patients were later diagnosed by another malignancy.
elsh et al. [4] reported that 28% of 136 patients with thymomaPEN  ACCESS
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acquired extrathymic cancers. The most common extrathymic can-
cer in their series was  colorectal carcinoma. Pan et al. [5] reported
a series of 192 patients with thymoma from Taiwan. The incidence
of extrathymic neoplasm was 8%, and the most common tumor
was gastric adenocarcinoma. Two patients had extrathymic tumors
before the diagnosis of thymoma. The secondary malignancies that
have been described in these patient series includes both common
cancers (e.g., cancers of the lung, thyroid, and prostate, and lym-
phomas) and rare malignancies (e.g., brain tumors, sarcomas, and
leukemias). Overall cancer risk has been estimated to be 3–4 times
higher in thymoma patients than in controls.
Malignant brain tumors are among the most distressful types of
cancer, not only for their poor prognosis, but also because of the
direct consequences on quality of life and cognitive function.
Some of the rare hereditary syndromes are associated with an
increased risk of glioma, including Cowden, Turcot, Li-Fraumeni,
neuroﬁbromatosis type 1 and type 2, tuberous sclerosis, and
familial schwannomatosis. Ionizing radiation is a recognized envi-
ronmental risk factor for glioma development [6]. Our patient
was not affected by any of the above-mentioned diseases. Cere-
bral malignant gliomas rarely show extracranial metastases. In the
literature, several anecdotal cases of dissemination to the bone,
leptomeninges, scalp, lymph–node, spine, bone marrow, liver,
peritoneum, parotid gland, lung, spleen and pancreas from oligo-
dendroglioma have been reported. The anaplastic variant showed
the most frequent tendency to metastasize. Our patient with simul-
taneous double malignancy had no evidence of metastatic lesion.
Treatment strategies in cases of double malignancy generally
involve treating the malignancy that is more advanced ﬁrst. In our
case we  concluded that synchronous double malignancy may be
treated successfully and both sites should be treated fully as if they
were occurring separately.
4. Conclusion
Clinicians should be aware of the possibility of synchronous
malignancies in order to use screening procedures in patients with
reported increased risk of double malignancy. Such clinical alert-
ness may  lead to a better outcome for double primary tumor cases.
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